NCT03114982View on ClinicalTrials.gov

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

PHASE2CompletedINTERVENTIONAL

Enrollment

152

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions

Varicella

Interventions

BIOLOGICAL

NBP608

Preparation of the Oka/SK strain of live, attenuated varicella virus

BIOLOGICAL

Varivax

Preparation of the Oka/Merck strain of live, attenuated varicella virus

Trial Locations (1)

1781

Research Insitute for Torpical Medicine, Muntinlupa City

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT03114982 - The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age | Biotech Hunter | Biotech Hunter